dihydrofolate reductase inhibitors (Basilea)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namedihydrofolate reductase inhibitors (Basilea)
Drug Alias Nameantifolates (Basilea Pharmaceutica)BAL-0030543BAL-30545BAL-30544BAL-30543 +[6] 
ClassificationSmall molecules
Mechanisms of ActionDihydrofolate reductase inhibitors
TargetsDihydrofolate reductase
Therapy Area/IndicationsGram-Positive Bacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBasilea Pharmaceutica International Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBasilea Pharmaceutica International Ltd
Active IndicationsN/A
Inactive IndicationsGram-Positive Bacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A